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Abstract
Traditionally bacteria have been considered as either 
pathogens, commensals or symbionts. The mammal 
gut harbors 1014 organisms dispersed on approximately 
1000 different species. Today, diagnostics, in contrast 
to previous cultivation techniques, allow the identifica-
tion of close to 100% of bacterial species. This has 
revealed that a range of animal models within differ-
ent research areas, such as diabetes, obesity, cancer, 
allergy, behavior and colitis, are affected by their gut 
microbiota. Correlation studies may for some diseases 
show correlation between gut microbiota composition 
and disease parameters higher than 70%. Some dis-
ease phenotypes may be transferred when recolonizing 
germ free mice. The mechanistic aspects are not clear, 
but some examples on how gut bacteria stimulate re-
ceptors, metabolism, and immune responses are dis-
cussed. A more deeper understanding of the impact of 
microbiota has its origin in the overall composition of 
the microbiota and in some newly recognized species, 
such as Akkermansia muciniphila , Segmented filamen-
tous bacteria and Faecalibacterium prausnitzii , which 
seem to have an impact on more or less severe disease 
in specific models. Thus, the impact of the microbiota 
on animal models is of a magnitude that cannot be 
ignored in future research. Therefore, either models 
with specific microbiota must be developed, or the mi-
crobiota must be characterized in individual studies and 
incorporated into data evaluation.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
Key words: Animal models; Gut microbiota; Diabetes; 
Obesity; Cancer; Allergy; Behavior; Colitis
Core tip: Full characterization of the gut microbiota of 
animal models has revealed that animal models within 
different research areas, such as diabetes, obesity, 
cancer, allergy, behavior and colitis, are highly affected 
by their gut microbiota. The mechanistic aspects are 
not clear; however, the impact of the microbiota on 
animal models is of a magnitude that cannot be ig-
nored in future research. Therefore, either models with 
specific microbiota must be developed, or the micro-
biota must be characterized in individual studies and 
incorporated into data evaluation.
Hansen AK, Friis Hansen CH, Krych L, Nielsen DS. Impact of 
the gut microbiota on rodent models of human disease. World J 
Gastroenterol 2014; 20(47): 17727-17736  Available from: URL: 
http://www.wjgnet.com/1007-9327/full/v20/i47/17727.htm  DOI: 
http://dx.doi.org/10.3748/wjg.v20.i47.17727
INTRODUCTION
Host-microbiota relationship
The gut is an ideal incubation chamber for bacteria 
adapted to the mammal body temperature and the anaer-
obic environment. Thousands of  years of  co-existence 
has led to such adaptation, and the mammal gut harbors 
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1014 organisms dispersed over approximately 1000 dif-
ferent species, dependent on how the cut-offs are set for 
similarity. Within the traditional approach to laboratory 
animal bacteriology, bacteria have been considered as 
either pathogens, commensals or symbionts; however, 
there seems to be a need for a broader understanding 
of  this. When first inside the gut, the bacteria will be fed 
and will be allowed to propagate, while the host organ-
ism will benefit from otherwise unavailable products of  
microbial digestion. Generally, pathogenicity is not in 
the interest of  the microorganism, because it induces a 
strong and eradicating immune response from the host, 
and even in the case of  microbial victory in this battle, 
the end result may be the death of  the host and the need 
for the microbe to relocate to a new habitat. The host 
immune system, on the other hand, needs to protect the 
host from invasion without being so aggressive that it 
loses the microbe and thereby all its benefits.
Complexity of microbial impact on the host
A more advanced understanding of  the impact of  the 
microbiota takes into consideration both the overall 
composition and the balance between the members of  
the microbiota, as well as some newly recognized spe-
cies, which, by themselves, seem to have an effect on 
the specific models. Some of  these have a symbiotic ef-
fect, while others push disease development in a more 
detrimental direction. However, same species may act 
in favor of  the development of  one disease, while be-
ing more protective against another disease, and the 
mechanistic potential of  the species may differ between 
different parts of  the gut. For most of  these bacteria, it 
is their abundance, rather than their qualitative presence 
or absence, which are responsible for their effect on the 
host[1-4]. The microbiota is normally not very diverse in 
the upper part of  the gut, e.g. in the ileum, where there 
is a huge accumulation of  lymphatic tissue available for 
stimulation[3,5-10]. It gradually becomes more diverse as 
the gut contents pass through the large intestine and 
become feces (Figure 1)[3,5-11]. In both man and mouse, 
a microbiota with a low diversity is indicative of  an in-
creased risk of  developing inflammatory disease[12,13]. 
Furthermore, in animals, a microbiota that is roughly 
similar in the upper part of  the gut, may differ sub-
stantially in the lower part of  the gut and vice versa[3,14]. 
Finally, there might be essential differences between the 
effects of  the various species at different ages of  the 
animals, which may explain why some species favor the 
development of  one disease, while protecting against an-
other.
Modern microbiological identification techniques
Over recent decades, new methods based upon molecu-
lar biology diagnostics have been developed. Such meth-
ods, which include quantitative real-time polymerase 
chain reaction (qPCR) assays[15], pyrosequencing[16] and 
metagenomic sequencing, have permitted identification 
of  close to 100% of  the gut’s operational taxonomic 
units (OTU), which include both cultivable and non-
cultivable bacterial species, and in principle, viral, eukary-
otes and archea[17], although they are seldom specifically 
tested for at present. In contrast, previous cultivation 
techniques only allowed cultivation and identification of  
10%-20% of  the bacterial species present in the gut[18]. 
These molecular biology-based tools have enabled de-
tailed correlation studies. Such studies have revealed that 
a range of  animal models within a range of  different 
research areas are affected by their gut microbiota[19].
GENERAL MECHANISMS UNDERLYING 
THE GUT MICROBIOTA EFFECT
As described below, the impact of  the microbiota on an-
imal models is well documented, while the mechanisms 
underlying this are less clear. Some hypotheses, though, 
make more sense than others. As techniques for the 
full characterization of  the microbiota have been devel-
oped over the last decade, we are only now beginning to 
achieve an understanding of  how the microbiota actually 
exerts its effect on the host; however, some examples 
can be given.
Window of opportunity
In early life, there is a window for the induction of  oral 
tolerance in the gut[20]. This seems essential to avoid in-
flammatory disease later in life[21]. Molecular structures 
in bacteria known as Microbial-associated molecular patterns 
(MAMP) stimulate pattern-recognition receptors (PRR) 
in the host, thereby inducing innate responses[22]. Among 
the most important PRRs are the Toll-like receptors 
(TLR), which are present in different types on a range of  
different cell types[22-29] (Figure 2). An important example 
of  a MAMP is lipopolysaccharides (LPS), which are 
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Figure 1  The approximate composition of the gut microbiota in the ileum, 
cecum and feces of mice[3,7,8,11,16].
important parts of  the cell wall of  Gram negative bacte-
ria[30], such as Proteobacteria[31], from which it stimulates 
TLR4. Another important example is peptidoglycan, 
found in the cell walls of  Gram positive bacteria, which 
stimulates TLR2[32] and flagellin deriving from flagellated 
bacteria, leading to stimulation of  TLR5[33]. Therefore, 
as different types of  MAMPs stimulate different TLR’s 
dispersed on a variety of  different cell types[23], and as 
MAMPs are also dispersed and shared between members 
of  the microbiota[22], there is a vast range of  innate host 
responses to bacteria.
Adult life stimulation
The age of  the animal also makes a difference. For 
example, stimulation of  TLR1, TLR2 and TLR4 in early 
life leads to higher production of  interleukin (IL)-6 than 
stimulation later in life[34]. Germ free animals have more 
T helper cells type 2 (TH2) and less TH1 cells[35], as the 
stimulation of  the gut lamina propria dendritic cells, e.g. 
by polysaccharide A (PSA) from Bacteroides fragilis, induces 
IL-12 secretion, which favors TH1 at the cost of  TH2[36]. 
Host-bacterial interactions, probably mediated through 
glucagon-like peptide 2 (GLP-2), seem to control the gut 
barrier function[37]. Metabolic endotoxaemia is responsible 
for the phenomenon whereby excess intake of  dietary 
fat increases plasma LPS levels[38,39], which in mice, is 
a sufficient molecular mechanism to trigger metabolic 
diseases, such as obesity and diabetes[40].
EXAMPLES OF SOME ANIMAL 
MODELS UNDER IMPACT OF THE GUT 
MICROBIOTA
Impact of germ free status
The clearest documentation of  a general microbial impact 
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Figure 2  Examples of some theories on potential pathways for the impact of gut microbiota on animal models of human disease. Bacterial colonization may 
double the density of capillaries in the small intestinal epithelium, thereby promoting intestinal monosaccharide absorption[28]. Undigested food components may be 
fermented into SCFAs and subsequently act as signals for GPRs of importance for the development of obesity[26,29]. Bacteria may express several key enzymes rele-
vant for hepatic lipogenesis[27,50], and hepatic and muscular fatty acid oxidation[31]. Molecular structures in the cell walls of bacteria may act as MAMPs, which stimulate 
TLRs on the host cells to induce innate immune responses.  The complex of TLR1, TLR2, TLR6 and TLR10 is expressed on a range of cell types such as enterocytes, 
macrophages, dendritic cells, natural killer cells, mast cells, T cells, B cells, neutrophilic cells and Schwann cells, and may be stimulated by various MAMPs, e.g. pep-
tidoglycan, from Gram positive bacteria cell types[21,23-25,31-33]. TLR4, expressed by e.g. macrophages, dendritic cells, mast cells, natural killer cells and enterocytes, is 
stimulated by lipopolysaccharides from Gram negative bacteria[30], while flagellin from various bacteria may stimulate TLR5 expressed by e.g. mucosal dendritic cells 
and macrophages[33]. Mucin-degrading Akkermansia muciniphila may reduce the mucus layer to increase TLR-stimulation[79]. SCFAs: Short chain fatty acids; GPR: 
G-protein receptors; MAMP: Microbial-associated molecular patterns; TLR: Toll-like receptors.
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Table 1  Examples of rodent models in which germ free status 
has a documented impact
Impact of fluctuations in the gut microbiota composition
Within animal models of  the metabolic syndrome, there 
seems to be an association between the gut microbiota 
and at least some of  the metabolic parameters. For ex-
ample, in leptin-deficient obese mice, there is a strong 
correlation between glycated hemoglobin levels and 
the composition of  the gut microbiota[1]. Further, these 
mice have significantly more Firmicutes and fewer Bac-
teriodetes members compared with their wild-type and 
heterozygous litter mates[10]. Their obese phenotype may 
be transferred with the microbiota by recolonizing germ 
free lean wild-type mice[65]. In C57 Black substrain 6 
(C57BL/6) mice on both high and low calorie diet, con-
tinuous oral ampicillin improves glucose tolerance[66,67]. 
However, this effect is mainly caused by an early life 
impact on glucose tolerance, and the effect ceases im-
mediately after termination of  treatment; thereafter, the 
glucose tolerance may even decrease[68,69]. Several stud-
ies describe cross-talk between the brain and the gut 
through both the vagal system and the hypothalamus-
pituitary-adrenal (HPA) axis[70]. Stressing animal models 
changes their microbiota[71], and the composition of  the 
gut microbiota has an impact on responses in rodent 
stress tests[72,73]. Innate immune system cytokines, such as 
IL-1, IL-6 and tumor necrosis factor α (TNFα), which 
may originate from a gut microbiota provocation, induce 
“sickness behavior”, changing the priorities of  the organ-
ism to enhance recovery and survival[74]. However, me-
tabolites formed by microbial decomposition in the gut 
may also have a direct impact on the brain[75]. In mouse 
models of  atopic dermatitis, more than 70% of  the vari-
ation observed in the local tissue cytokine response may 
be shared with the variation in gut microbiota[76]. Chang-
es in the structure of  the microbial community seem 
to reduce the number, as well as the size, of  tumors in 
azoxymethane/dextran sodium sulfate (AOM/DSS) 
colon cancer-induced mice, and tumor induction may be 
achieved by colonizing germ free mice with microbiota 
from induced mice[77].
EXAMPLES OF THE IMPACTS OF 
SPECIFIC BACTERIAL SPECIES
Verrucomicrobioa
Akkermansia muciniphila is a Gram negative bacterium, 
which in mice is the only species belonging to the phylum 
Verrucomicrobia[78]. It interacts via its mucin degrading 
capabilities with enteroendocrine cells to modulate gut 
barrier function, and it is capable of  producing certain 
short chain fatty acids (SCFA’s) with a direct action on the 
receptor G-protein receptor 43 (GPR43)[79]. Abundance 
of  A. muciniphila is reduced in mice with obesity and type 
2 diabetes[80], and it gradually disappears as aging leptin 
deficient obese mice develop insulin resistance[1]. In non-
obese diabetic (NOD) mice it becomes more abundant 
when mice are fed a gluten-free diet, which decreases 
the incidence of  type 1 diabetes[81]. Early life treatment 
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Model Disease
Models with increased disease incidence 
or severity
   β-lactoglobulin induced mouse[51] Allergy
   NOD mouse[42] Type 1 diabetes
   MyD88 KO NOD mouse[42] Type 1 diabetes
   Restrained mouse[43] Stress
Models with decreased disease incidence 
or severity
   Ovalbumin-specific TCR TG mouse[44] Allergy
   Swiss-Webster mouse[45] Anxiety
   Collagen induced rat[52] Arthritis
   HLA-B27 TG rat[53] Inflammatory bowel disease
   IL-2 KO mouse[54,55] Inflammatory bowel disease
   IL-10 KO mouse[56] Inflammatory bowel disease
   TCRα KO mouse[57] Inflammatory bowel disease
   Dextran sulfate sodium induced mouse[46] Inflammatory bowel disease
   SAMP1/Yit mouse[47] Inflammatory bowel disease
   Adoptive T-cell transfer in the mouse[48] Inflammatory bowel disease
   Carrageenan, LPS, or formalin induced 
   mouse[49]
Inflammatory pain
   C57BL/6 mouse[65] Obesity
   C57BL/6 mouse[65] Type 2 diabetes
on rodent models is observed when comparing a conven-
tional model with a microbiota with a germ free version. 
In several studies, this has revealed essential differences 
in disease expression (Table 1)[22,41-57]. Although germ free 
mice eat more, they are leaner, and they have less body 
fat compared with conventional mice because they are 
less efficient in extracting energy from their diet[50]. Germ 
free mice have increased expression of  obesity-related 
peptides, such as glucagon-like peptide 1 (GLP-1) in the 
brain[58], which is relevant, because central GLP-1 reduces 
food intake in rats[59]. Germ free mice also behave differ-
ently from microbiota-harboring mice and this behavior 
may be normalized by colonization[43]. However, for this 
phenotype there also seems to be an important time win-
dow in early life[60]. Germ free mice with a mutation caus-
ing a defect in the skin barrier suffer from a more severe 
B-lymphoproliferative disorder, because they express sig-
nificantly higher levels of  the proinflammatory cytokine 
thymic stromal lymphopoietin[61]. Inflammatory bowel dis-
ease (IBD) occurs either because of  a TH1/TH17 response 
(Crohn’s disease) or a TH2 response (ulcerative colitis) to 
gut commensals[62]. Therefore, IBD under germ free con-
ditions does not develop at all in, e.g. Human Leucocyte 
Antigen subtypes B27 (HLA-B27) transgenic rats[53] and 
IL-10 knockout mice[56]. For the IL-10 knockout mice[63] 
it does not occur even under barrier protected conditions 
(Table 1). IL-2 knockout mice may, under germ free con-
ditions, show mild focal intestinal inflammation[64] (Table 
1).
NOD: Non-obese diabetic; MyD88: Myeloid differentiation primary 
response gene 88; KO: Knockout; TCR: T cell receptor; TG: Transgenic; 
HLA-B27: Human leucocyte antigen subtype B27; IL-2: Interleukin 2; 
SAMP1/Yit: Senescence accelerated mice prone line 1 Yakult; LPS: Lipo-
polysaccharide.
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with vancomycin in NOD mice allows A. muciniphila to 
become a dominant gut microbiota member, which re-
duces the incidence of  type 1 diabetes[3], but enhances 
susceptibility to allergic asthma[82], which is in accordance 
with other studies showing allergy and diabetes to coun-
teract one another in NOD mice[83,84]. Induction of  IBD 
in mice with dextran sodium sulfate (DSS) reduces the 
number of  extracellular vesicles derived from A. muciniph-
ila, and feeding DSS induced mice such vesicles reduces 
the severity of  IBD[85], which fits well with observations 
in humans[4]. However, it not only reduces the severity of  
diseases: its presence is correllated with higher severity 
when infecting mice with Salmonella typhimurium[86], and 
AOM/DSS colon cancer-induced mice have an increased 
abundance of  A. muciniphila[77], which may be explained 
by its ability to downregulate the natural killer cell recep-
tor, NKG2D, which is part of  the anti-carcinogenic de-
fense[87].
Firmicutes
Segmented filamentous bacteria (SFB’s) are clostridia-re-
lated Gram-positive bacteria[88]. The term has been applied 
for decades to describe intestinal bacteria of  a uniform 
morphology[89]. However, today the term refers to one 
single species, also known as Candidatus Savagella[90]. SFBs 
induce secretion of  the pro-inflammatory cytokine IL-17 
from TH17 cells[91], which in the adult mouse is correlated 
with a low number of  regulatory T cells[92]. The presence 
of  SFB’s differs between mice from different vendors[92], 
and SFB positive NOD mice have a significantly lower 
incidence of  type 1 diabetes compared with SFB nega-
tive ones[93]. In the adoptive transfer severe combined 
immune deficiency (SCID) mouse model of  IBD, SFBs 
are essential for the induction of  severe inflammation[48]. 
Furthermore, SFBs and the induced TH17 are important 
in the defense against intestinal pathogens. For example, 
mice infected with Citrobacter rodentium, a potent murine 
colon pathogen, exhibit severe symptoms if  they lack 
SFBs[91].
IBD in IL-10 knockout mice is enhanced by Enterococ-
cus fecalis[94,95], which is probably linked to its production of  
gelatinase[96].
Faecalibacterium prausnitzii is a clostridia-related bacte-
rium[97] linked to a protective effect against human Crohn’s 
disease[98]. Oral feeding of  F. prausnitzii reduced the sever-
ity of  2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced 
colitis in mice, and some studies indicated that this may 
also be the case in both multidrug resistance gene defi-
cient (mdr1a knockout)[99] and in the DSS-induced mouse 
models of  colitis[100].
High abundances of Lactobacillus spp. and bifidobac-
teria are correlated strongly with low levels of  inflamma-
tion in mice[101] and leptin in rats[102], which also fits well 
with these bacteria acting protectively against IBD in 
IL-10 knockout mice[103], allergic sensitization in mice[104], 
and myocardial infarction in rats[102]. Lachnospiraceae seems 
quantitatively correlated to improved glucose tolerance 
in leptin-deficient obese mice[1].
In stressed mice, there is correlation between their Fir-
micutes levels and their responses in the stress tests[73]. 
Ingestion of  Lactobacillus rhamnosus in mice regulates their 
emotional behavior and central γ-aminobutyric acid (GABA) 
receptor expression via the vagus nerve[72].
Bacteroidetes
A high abundance of  the Gram negative family Prevotel-
laceae, perhaps restricted to one unclassified genus, in 
the gut of  leptin-deficient obese mice correlated with 
impaired glucose tolerance[1].By contrast, in AOM/DSS 
induced colon cancer mice, a high abundance of  Pre-
votellaceae correlated with a low tumor burden[77]. P. copri, 
which has been correlated with the development of  ar-
thritis in humans, seems to increase the severity of  DSS 
induced colitis in mice[5]. Caspase-3 knockout mice exhibit 
a lower inflammatory response to DSS induction of  
colitis compared with wild-type mice; however, this pro-
tective effect of  the mutation is decreased by cohousing 
knockout mice with wild-type mice, which significantly 
increases the abundance of  Prevotella spp. in the knockout 
mice[105].
Bacteroides vulgatus seems to enhance IBD in HLA-B27 
transgenic rats[106] and IL-10 knockout mice[95], and in 
the Bio Breeding (BB) rat, a spontaneous type 1 diabetes 
model. The fecal microbiota differ and contain an in-
creased number of  Bacteroides spp. before onset of  diabe-
tes[107]. As in all other mammals, Bacteroides spp. form an 
important part of  the Bacteroidetes fraction of  the rodent 
gut[16]. These Gram negative bacteria are important for the 
processing of  complex molecules to simpler ones in the 
gut[108]: complex glycans are their key source of  energy[109]. 
B. fragilis toxins cause symptoms of  diarrhea and IBD 
in germ-free mice[110], and they induce colonic tumors 
strongly in multiple intestinal neoplasia (MIN) mice[111]. 
On the other hand, B. fragilis PSA, which is important for 
the inflammatory gut response to pathogens[36], also pro-
tects against Helicobacter hepaticus-induced colitis in mice; 
probably via the prevention of  IL-17 secretion[112]. Feeding 
the maternal immune activation (MIA) mouse model with 
B. fragilis reduces symptoms of  autism, which is probably 
linked to the normalization of  the levels of  a specific gut 
metabolite[113].
The abundance of  Alistipes spp., a bacterium of  the 
Rikinellaceae family, seems to increase when mice are 
stressed by grid floor housing[73].
Proteobacteria
Escherichia coli enhances IBD in HLA-B27 overexpressing 
rats[106], although E. coli Nissle stabilizes the enteric bar-
rier in mice[114]. When reducing type 1 diabetes by pre-
weaning treatment of  NOD mice with vancomycin, a 
vast increase in the abundance of  Proteobacteria in the 
pups was observed[3].
Actinobacteria
Bifidobacterium spp. in rodents have a positive impact on 
the regulatory  and innate immunity[101,115]. Perinatal sup-
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plementation of  B. longum reduced TH1 and TH2 responses 
in allergen sensitized mice[104]. On the other hand, their 
numbers are also increased in gluten-fed NOD mice with 
a high incidence of  type 1 diabetes compared with NOD 
mice on a gluten-free diet[81].
DISCUSSION
The information gained over the last decade on how 
the entire microbiota, as well as some of  its individual 
members, affect animal models of  very different types, 
has prompted the scientific community to incorporate 
this in future production and quality assurance of  animal 
models. It is not possible to regard these matters from a 
“Specific pathogen-free” concept, as some of  the spe-
cies act in favor of  the development of  one disease, 
while against the development of  another disease, e.g. 
SFB’s both protect against type 1 diabetes and induces a 
TH17 response in favor of  the development of  Crohn’s 
disease. Furthermore, the balance between the different 
fractions of  the microbiota is also likely to make a dif-
ference. Ultimately, it is often a quantitative rather than 
a qualitative presence that makes the difference. There-
fore, it is likely that we will see more tailor-made rodent 
models, i.e. commercial breeders and research groups 
have sought to produce animals with a specific microbi-
ota for the conditions under test. One obvious idea may 
be to breed such animals by selective breeding; however, 
this does not seem to increase the microbiota similarity, 
although the microbiota of  offspring show a clear clus-
tering with the mother’s microbiota[116,117]. It is probably 
rational to inoculate germ free mice with a tailor-made 
microbiota around weaning, as they are conventionalized 
in SPF conditions[118]. The window for induction of  oral 
tolerance in animal models may also be turned around, 
such that a low bacterial stimulation in the open phase 
of  this window may be essential to develop target diseas-
es in the model. When stimulated later on, the nature of  
this stimulation is also essential, because commonly used 
disease models in rodents are driven by specific subsets 
of  T cells[19]. Another alternative will be to characterize 
the microbiota composition for animals in sensitive stud-
ies and incorporate this in the data evaluation by chemo-
metric or multifactorial statistical means. The impact of  
the gut microbiota on animal models is of  a magnitude 
that cannot be neglected in the future.
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